Non-enzymatic and enzymatic activation of mitomycin C: Identification of a unique cytosolic activity

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 263-271

  Joseph, Pius ^a   Xu, Yeuhang ^a   Jaiswal, Anil K ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CYTOCHROME P450 REDUCTASE; ENDOGENOUS COMPOUND; MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CONTROLLED STUDY; CYTOSOL; DNA ADDUCT; DRUG ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMALS; CELL LINE; CYTOSOL; DNA; DNA, COMPLEMENTARY; ENZYME ACTIVATION; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MITOMYCIN; NAD(P)H DEHYDROGENASE (QUINONE); NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDOREDUCTASES; PROTEIN BINDING;

EID: 0030034266     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960117)65:2<263::AID-IJC22>3.0.CO;2-D     Document Type: Article

References (22)

1. BIZANEK, R., CHOWDARY, D., ARAI, H., KASAI, M., HUGHES, C.S., SARTORELLI, A.C., ROCKWELL, S. and TOMASZ, M., Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicoumarol on adduct patterns. Cancer Res., 53, 5127-5134 (1993).
2. BLIGH, H.F.J., BARTOSZEK, A., ROBSON, C.N., HICKSON, I.D., KASPER, C.B., BEGGS, J.D. and WOLF, C.R., Activation of mitomycin C by NADPH: cytocbrome P450 reductase. Cancer Res., 50, 7789-7792 (1990).
3. IYER, V.N. and SZYBALSKI, W., A molecular mechanism of mitomycin C action: linking of complementary DNA strands. Proc. nat. Acad. Sci. (Wash.), 50, 355-362 (1963).
4. 2 gene locus on chromosome 6. Biochemistry, 29, 1899-1906 (1990).
5. 1 (DT-diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. nat. Acad. Sci. (Wash.), 91, 8413-8417 (1994).
6. KEYES, S.R., HEIMBROOK, D.C., FRACASSO, P.M., ROCKWELL, S., SLIGAR, S.G. and SARTORELLI, A.C., Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Adv. Enzyme Regul., 23, 291-307 (1985).
7. MARSHALL, A.S., PATERSON, M.C. and RUTH, A.M., Deficient activation of a human cell strain leads to mitomycin C resistance under aerobic but not hypoxic conditions. Brit. J. Cancer, 59, 341-346 (1989a).
8. MARSHALL, R.S., RUTH, A.M. and PATERSON, M., Reply to the letter from Workman et al. Brit. J. Cancer, 60, 803 (1989b).
9. NACHLAS, M.M., MARGULIES, S.I., GOLDBERG, J.D. and SELIGMAN, A.M., The determination of lactic dehydrogenase with a tetrazolium salt. Anal. Biochem., 1, 317-326 (1960).
10. PAN, S.S., ANDREWS, P.A., GLOVER, C.J. and BACHUR, N.R., Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P450 reductase and xanthine oxidase. J. biol. Chem., 259, 959-966 (1984).
11. PRITSOS, C.A., PARDINI, L.L., ELLIOT, A.J. and PARDINI, R.S., Relationship between the antioxidant enzyme DT-diaphorase and tumor response to mitomycin C treatment. In: M.G. Simic and K.A. Taylor (eds.), Oxygen radicals in biology and medicine, p. 713, Plennum, New York (1987).
12. PROCHASKA, H.J. and TALALAY, P., Purification and characterization of two isofunctional forms of NAD(P)H: quinone reductase from mouse liver. J. biol. Chem., 261, 1372-1378 (1986).
13. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anti-cancer antibiotic mitomycin C. Mutation Res., 179, 75-88 (1987).
14. ROSS, D., BEALI, H., TRAVER, R.D., SIEGEL, D., PHILLIPS, R.D. and GIBSON, N.W., Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol. Res., 6, 493-500 (1994).
15. SARTORELLI, A.C., HODNICK, W.F., BELCOURT, M.F., TOMASZ, M., HAFFTY, B., FISCHER, J.J. and ROCKWELL, S., Mitomycin C: a proto-type bioreductive agent. Oncol. Res., 6, 501-508 (1994).
16. SCHLAGER, J.J. and POWIS, G., Mitomycin C is not metabolized but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor) oxidoreductase. Cancer Chemother. Pharmacol., 22, 126-130 (1988).
17. SHAW, P.M., REISS, A., ADESNIK, M., NEBERT, D.W., SCHEMBRI, J. and JAISWAL, A.K., The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS1 cells is identical to diaphorase 4. Europ. J. Biochem., 195, 171-176 (1991).
18. SIEGEL, D., BEALL, H., SENEKOWITSCH, C., KASAI, M., ARAI, H., GIBSON, N. and ROSS, D., Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry, 31, 7879-7885 (1992).
19. TOMASZ, M., LIPMAN, R., CHOWDARY, D., PAWLAK, J., VERDINE, G.L. and NAKANISHI, K., Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science, 235, 1204-1208 (1987).
20. VERWEIJ, J. and PINEDO, H.H., Mitomycin C. In: H.M. Pinedo, B.A. Chabner and D.L. Longo (eds.), Cancer chemotherapy and biologial modifiers, Annual 11, pp. 63-73, Elsevier, Amsterdam (1990).
21. WORKMAN, P., Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol. Res., 6, 461-475 (1994).
22. WORKMAN, P., WALTON, M.I., POWIS, G. and SCHLAGER, J.J., DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs. Brit. J. Cancer, 60, 800-802 (1989).